	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
Amarin	USD 12.54M	28.57M	2025-06
Amgen	USD 5.14B	775M	2025-12
Biogen	USD 573.2M	253.7M	2025-12
BioMarin Pharmaceutical	USD -24.17M	18.91M	2025-12
Cipla	INR 12.55B	6.4B	2025-12
CSL	USD 3.13B	1.17B	2025-12
Cytokinetics	USD -277.18M	169.36M	2025-09
Daiichi Sankyo	JPY 101.6B	22.81B	2025-03
Eli Lilly	USD 7.88B	378.1M	2025-09
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Geron	USD -9.47M	1.92M	2025-09
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Minerva Neurosciences	USD -4.36M	1.71M	2024-09
Moderna	USD -790M	582M	2025-12
Nektar Therapeutics	USD -31.81M	70K	2023-09
Pfizer	USD 6.08B	351M	2025-09
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Sanofi	EUR 4.84B	2.95B	2025-09
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
United Therapeutics	USD 379.5M	83.4M	2025-12
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12

Esperion Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.